San Diego, CA-based Pathway Genomics, a clinical laboratory facilitating precision medicine through genetic testing and mobile healthcare applications has raised over $40 million in Series E funding. This brings the total investment into Pathway Genomics to over $130 million. Investors in this round of funding include IBM Watson, Pathway's partner in the development of a mobile health application using artificial intelligence to provide personalized health and wellness guidance. The capital will
Read More